8H-thieno-[2,3-b]pyrrolizin-8-one compounds
US6071945A · kind A · utility
0Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 1999 |
| Grant date | Jun 6, 2000 |
| Priority date | — |
| Expiry date | Jul 26, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound selected from those of formula (I): ##STR1## wherein: R.sub.1 represents hydrogen, halogen, alkyl, nitro, hydroxy, alkoxy, trihaloalkyl, trihaloalkoxy or optionally substituted amino, PA1 R.sub.2 represents optionally substituted aryl or heteroaryl, PA1 R.sub.3 represents hydrogen, halogen, alkyl, nitro, hydroxy, alkoxy, trihaloalkyl, trihaloalkoxy or optionally substituted amino, PA2 their isomers and addition pharmaceutically-acceptable acid or base salts thereof and medicinal products containing the same are useful in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.